No evidence for interleukin-4 gene conferring susceptibility to myasthenia gravis

J Neuroimmunol. 1998 Dec 1;92(1-2):208-11. doi: 10.1016/s0165-5728(98)00186-6.

Abstract

A variable number of tandem repeat (VNTR) and a dinucleotide repeat polymorphism in IL-4 gene were examined in Swedish myasthenia gravis (MG) patients and ethnically matched healthy individuals. There were no associations between these polymorphisms and MG patients as a whole group or stratified by clinical and pathological parameters and genetic markers in MHC gene (TNF-alpha NcoI allele 2) and IL-1 gene (IL-1beta TaqI allele 2). This lack of association between the IL-4 gene and disease contrasts to our previous results showing that MG is associated with higher secretor phenotypes of two prototype proinflammatory cytokine (TNF-alpha and IL-1) genes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Interleukin-4 / genetics*
  • Male
  • Microsatellite Repeats / genetics
  • Minisatellite Repeats / genetics
  • Myasthenia Gravis / genetics*
  • Polymorphism, Genetic / genetics
  • Reference Values

Substances

  • Interleukin-4